YOUNG KWON - 23 Aug 2024 Form 4 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Role
Director
Signature
/s/ Young Kwon, by Adam S. Grossman as Attorney-in-fact
Issuer symbol
ADMA
Transactions as of
23 Aug 2024
Net transactions value
-$1,095,600
Form type
4
Filing time
27 Aug 2024, 21:00:24 UTC
Previous filing
28 Feb 2024
Next filing
21 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADMA Common Stock Sale $1,095,600 -60,000 -20% $18.26 241,441 23 Aug 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $18.25 to $18.27. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F2 Includes, as of the transaction date, (i) 12,020 restricted stock units ("RSUs") granted on February 26, 2024, which will vest in full on February 26, 2025, subject to the Reporting Person's continued service as of the applicable vesting date; and (ii) 229,421 shares of common stock owned by the Reporting Person.

Remarks:

Exhibit 24 - Power of Attorney